VHL, pVHL	von Hippel–Lindau tumour suppressor
HIFs	Hypoxia-inducible factors
ccRCC	Clear cell renal cell carcinoma
AHR	Aryl hydrocarbon receptor
HIF-1β, ARNT	Aryl hydrocarbon receptor nuclear translocator
TCDD	Dioxin, 2,3,7,8-tetrachlorodibenzo-p-dioxin
AR	Androgen receptor
RB1	Retinoblastoma-associated protein
SAhRMs	Selective AHR modulators
bHLH-PAS	Basic helix–loop–helix-PER-ARNT-SIM transcription factors
pNETs	Non-functioning pancreatic neuroendocrine tumours
RCC	Renal cell carcinoma
VCB complex	Complex formed by pVHL, elongin-B, elongin-C, and Cullin-2
ELOB	Elongin-B
ELOC	Elongin-C
CUL2	Cullin-2
HIF-1α	Hypoxia-inducible factor 1-α
HSP90	Heat shock protein 90
p23	Prostaglandin E synthase 3
XAP2	AH receptor-interacting protein
XREs	Xenobiotic-responsive elements
DREs	Dioxin-responsive elements
Cyp1a	Cytochrome P450, family 1, subfamily A, polypeptide 1
Cyp1b	Cytochrome P450, family 1, subfamily B, polypeptide 1
GSTA1	Glutathione S-transferase A1
EPHX1	Epoxide hydrolase 1
PAI2	Plasminogen activator inhibitor 2
p300	Histone acetyltransferase p300
CREBBP	CREB-binding protein
NCOA1/2/3	Nuclear receptor coactivator 1/2/3
NRIP1	Nuclear receptor-interacting protein 1
ER	Estrogen receptor
HepaRG	Human hepatic in vitro line
MCF7	Human breast cancer cell line (Michigan Cancer Foundation-7)
HepG2	Human liver cancer cell line
786-O	Human renal cancer cell line
EGA	European Genome–Phenome Archive
TCGA	The Cancer Genome Atlas
GEO	Gene Expression Omnibus
HR	Hazard ratio
PPI	Protein–protein interaction
DEGs	Differentially expressed genes
GSTA5	Glutathione S-transferase A5
GSTM2	Glutathione S-transferase Mu 2
UGT2B11	UDP-glucuronosyltransferase 2B11
PPIN	Protein–protein interaction network
VEGF-A/C	Vascular endothelial growth factor A/C
CDK2/4	Cyclin-dependent kinase 2/4